GALT - Galectin Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5129.62M
Enterprise Value 3145.35M
Trailing P/E N/A
Forward P/E 1-5.00
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-8.95

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-101.77%
Return on Equity (ttm)-245.84%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.25M
Net Income Avi to Common (ttm)-17.47M
Diluted EPS (ttm)-0.49
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.05M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.29
Book Value Per Share (mrq)-0.22

Cash Flow Statement

Operating Cash Flow (ttm)-15.89M
Levered Free Cash Flow (ttm)-10.17M

Trading Information

Stock Price History

Beta 3.53
52-Week Change 35.81%
S&P500 52-Week Change 311.79%
52 Week High 36.74
52 Week Low 31.28
50-Day Moving Average 34.41
200-Day Moving Average 33.67

Share Statistics

Avg Vol (3 month) 3516.35k
Avg Vol (10 day) 3621.03k
Shares Outstanding 537.57M
Float 33.17M
% Held by Insiders 120.12%
% Held by Institutions 19.79%
Shares Short 31.09M
Short Ratio 34.35
Short % of Float 33.48%
Shares Short (prior month) 31.04M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/6
Last Split Date 3Mar 23, 2012